These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 30991063)

  • 1. Specific targeting of a pore-forming toxin (listeriolysin O) to LHRH-positive cancer cells using LHRH targeting peptide.
    Kheirandish MH; Jaliani HZ; Rahmani B; Nikukar H
    Toxicon; 2019 Jun; 164():82-86. PubMed ID: 30991063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MCF-7 Cell Line by Listeriolysin O Pore Forming Toxin Fusion with AHNP Targeted Peptide.
    Fotoohi-Ardakani G; Kheirollahi M; Zarei Jaliani H; Noorian M; Ansariniyia H
    Adv Biomed Res; 2019; 8():33. PubMed ID: 31259162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutants of listeriolysin O for enhanced liposomal delivery of macromolecules.
    Walls ZF; Goodell S; Andrews CD; Mathis J; Lee KD
    J Biotechnol; 2013 Apr; 164(4):500-2. PubMed ID: 23416330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide.
    Dharap SS; Wang Y; Chandna P; Khandare JJ; Qiu B; Gunaseelan S; Sinko PJ; Stein S; Farmanfarmaian A; Minko T
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12962-7. PubMed ID: 16123131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human lymphocytic B-leukemia cell line treatment with the bacterial toxin listeriolysin O and rituximab (anti-CD20 antibody): Effects of similar localization of their receptors.
    Gryzik M; Grzywocz Z; Wasilewska D; Kawiak J; Stachowiak R; Bielecki J; Hoser G
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):329-40. PubMed ID: 26216910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cells.
    Stachowiak R; Łyżniak M; Grabowska M; Roeske K; Jagielski T; Bielecki J; Budziszewska BK; Hoser G; Kawiak J
    BMC Biotechnol; 2014 Aug; 14():77. PubMed ID: 25134983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant Production of a Novel Fusion Protein: Listeriolysin O Fragment Fused to S1 Subunit of Pertussis Toxin.
    Forghani H; Jamshidi Makiani M; Zarei Jaliani H; Boustanshenas M; Zahraei SM
    Iran Biomed J; 2021 Jan; 25(1):33-40. PubMed ID: 33129237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ability of luteinizing hormone releasing hormone-Pseudomonas aeruginosa exotoxin 40 binding to LHRH receptor on human liver cancer cells.
    Gong SL; Zhao G; Zhao HG; Lu WT; Liu GW; Zhu P
    World J Gastroenterol; 2004 Oct; 10(19):2870-3. PubMed ID: 15334689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Listeriolysin O as a strong immunogenic molecule for the development of new anti-tumor vaccines.
    Sun R; Liu Y
    Hum Vaccin Immunother; 2013 May; 9(5):1058-68. PubMed ID: 23399758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid purification of recombinant listeriolysin O (LLO) from Escherichia coli.
    Churchill RL; Lee H; Hall JC
    J Ind Microbiol Biotechnol; 2005 Aug; 32(8):355-63. PubMed ID: 16052337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Role of
    Vdovikova S; Luhr M; Szalai P; Nygård Skalman L; Francis MK; Lundmark R; Engedal N; Johansson J; Wai SN
    Front Cell Infect Microbiol; 2017; 7():154. PubMed ID: 28516064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Listeriolysin O as cytotoxic component of an immunotoxin.
    Bergelt S; Frost S; Lilie H
    Protein Sci; 2009 Jun; 18(6):1210-20. PubMed ID: 19472336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Listeriolysin O enhances cytoplasmic delivery by Her-2 targeting liposomes.
    Kullberg M; Owens JL; Mann K
    J Drug Target; 2010 May; 18(4):313-20. PubMed ID: 20201742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entangling roles of cholesterol-dependent interaction and cholesterol-mediated lipid phase heterogeneity in regulating listeriolysin O pore-formation.
    Lata K; Anderluh G; Chattopadhyay K
    Biochem J; 2024 Oct; 481(19):1349-1377. PubMed ID: 39268843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteinizing hormone-releasing hormone receptor-mediated delivery of mitoxantrone using LHRH analogs modified with PEGylated liposomes.
    He Y; Zhang L; Song C
    Int J Nanomedicine; 2010 Sep; 5():697-705. PubMed ID: 20957221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prokaryotic expression of Listeria monocytogenes (LM) hly and development of monoclonal antibodies against listeriolysin O (LLO)].
    Luo Z; Liu R; Zheng S
    Sheng Wu Gong Cheng Xue Bao; 2009 Nov; 25(11):1652-7. PubMed ID: 20222463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic delivery of viral nucleoprotein by listeriolysin O-liposome induces enhanced specific cytotoxic T lymphocyte response and protective immunity.
    Mandal M; Kawamura KS; Wherry EJ; Ahmed R; Lee KD
    Mol Pharm; 2004 Jan; 1(1):2-8. PubMed ID: 15832496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pt-Mal-LHRH, a Newly Synthesized Compound Attenuating Breast Cancer Tumor Growth and Metastasis by Targeting Overexpression of the LHRH Receptor.
    Calderon LE; Keeling JK; Rollins J; Black CA; Collins K; Arnold N; Vance DE; Ndinguri MW
    Bioconjug Chem; 2017 Feb; 28(2):461-470. PubMed ID: 27997127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic Activity of LLO Y406A Is Targeted to the Plasma Membrane of Cancer Urothelial Cells.
    Resnik N; Tratnjek L; Kreft ME; Kisovec M; Aden S; Bedina Zavec A; Anderluh G; Podobnik M; Veranič P
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid Remodeling of the Host Epithelial Cell Proteome by the Listeriolysin O (LLO) Pore-forming Toxin.
    Malet JK; Impens F; Carvalho F; Hamon MA; Cossart P; Ribet D
    Mol Cell Proteomics; 2018 Aug; 17(8):1627-1636. PubMed ID: 29752379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.